NetworkNewsBreaks – Organigram Holdings Inc. (TS
Post# of 88
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) today announced its receipt of Health Canada approval for the licensing of 17 additional cultivation rooms within its facility’s Phase 4A/4B perimeter. According to the update, approval of the additional licensed cultivation space increases annual target production capacity to 61,000 kg. “Sustainable growth, exceptional quality and constant innovation are the pillars of our overall strategic approach,” Organigram CEO Greg Engel said in the news release. “We are proud to continue to increase our physical capacity to meet the needs of cannabis consumers across the country while also bringing new thinking and technology to our production.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer